Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Ridker

Showing results (41-50 of 203) with videos related to

Pageof 21
Sort By:
JAMA|August 14, 1996
Should survivors of myocardial infarction with low ejection fraction be routinely referred to arrhythmia specialists?W G Stevenson, P M Ridker
Annals of Epidemiology|September 1, 1994
Lipoprotein(a) and risks of cardiovascular diseaseP M Ridker, C H Hennekens
The Annals of Thoracic Surgery|November 1, 1991
Surgical management of carcinoid heart diseaseP M Ridker, F J Schoen
Circulation|March 1, 1991
Hemostatic risk factors for coronary heart diseaseP M Ridker, C H Hennekens
Annals of Internal Medicine|February 12, 1998
Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspectiveD T Price, P M Ridker
Circulation|October 15, 1996
Age and thrombolytic therapyP M Ridker, C H Hennekens
Circulation Research|October 27, 2001
Novel clinical markers of vascular wall inflammationG J Blake, P M Ridker
Journal of Internal Medicine|October 9, 2002
Inflammatory bio-markers and cardiovascular risk predictionG J Blake, P M Ridker
European Heart Journal|June 4, 2002
Do atherosclerosis and type 2 diabetes share a common inflammatory basis?A D Pradhan, P M Ridker
Annals of Epidemiology|October 1, 1990
Racial differences in coronary heart disease incidence and mortality. Methodologic mythology?J E Manson, P M Ridker
Pageof 21

Showing results (41-50 of 203) with videos related to

Sort By:
Pageof 21
JAMA|August 14, 1996
Should survivors of myocardial infarction with low ejection fraction be routinely referred to arrhythmia specialists?W G Stevenson, P M Ridker
Annals of Epidemiology|September 1, 1994
Lipoprotein(a) and risks of cardiovascular diseaseP M Ridker, C H Hennekens
The Annals of Thoracic Surgery|November 1, 1991
Surgical management of carcinoid heart diseaseP M Ridker, F J Schoen
Circulation|March 1, 1991
Hemostatic risk factors for coronary heart diseaseP M Ridker, C H Hennekens
Annals of Internal Medicine|February 12, 1998
Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspectiveD T Price, P M Ridker
Circulation|October 15, 1996
Age and thrombolytic therapyP M Ridker, C H Hennekens
Circulation Research|October 27, 2001
Novel clinical markers of vascular wall inflammationG J Blake, P M Ridker
Journal of Internal Medicine|October 9, 2002
Inflammatory bio-markers and cardiovascular risk predictionG J Blake, P M Ridker
European Heart Journal|June 4, 2002
Do atherosclerosis and type 2 diabetes share a common inflammatory basis?A D Pradhan, P M Ridker
Annals of Epidemiology|October 1, 1990
Racial differences in coronary heart disease incidence and mortality. Methodologic mythology?J E Manson, P M Ridker
Pageof 21